Skip to main content

MDAI

ADVERTISEMENT
Identification
Molecular formula
C12H17NO2
CAS number
82801-81-8
IUPAC name
1-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-ethyl-ethanamine
State
State

At room temperature, MDAI is typically in a solid state, usually as a fine powder or crystalline solid.

Melting point (Celsius)
163.00
Melting point (Kelvin)
436.15
Boiling point (Celsius)
318.00
Boiling point (Kelvin)
591.15
General information
Molecular weight
191.25g/mol
Molar mass
191.2520g/mol
Density
1.1450g/cm3
Appearence

MDAI is typically a white or off-white powder. It may appear as crystalline solid formations, indicating purity, or as a amorphous powder depending on its form and method of synthesis.

Comment on solubility

Solubility of 1-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-ethyl-ethanamine

The solubility of 1-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-ethyl-ethanamine, which is a complex organic compound, is influenced by several factors:

  • Polarity: This compound contains both hydrophobic and hydrophilic moieties, which may create a balance in its overall polarity. Therefore, its solubility can vary significantly in different solvents.
  • Solvent Type: It is generally more soluble in organic solvents, such as ethanol or methanol, due to the non-polar characteristics imparted by the benzodioxin structure.
  • Temperature: The temperature can play a crucial role in enhancing solubility; increased temperatures typically increase the solubility of solid substances.
  • pH Levels: The ionization of the amine group may vary with pH, influencing its solubility in aqueous environments significantly.

In practice, it has been observed that compounds similar to 1-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-ethyl-ethanamine demonstrate variable solubility, emphasizing that solubility is a multifaceted property shaped by the intricate balance of molecular interactions.

In conclusion, when assessing solubility, it is crucial to consider all these aspects to predict the behavior of this compound in different environments accurately.

Interesting facts

Exploring 1-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-ethyl-ethanamine

This intriguing compound, known as 1-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-ethyl-ethanamine, is noteworthy for several reasons, particularly in medicinal chemistry and drug discovery.

Key Characteristics

  • Structural Complexity: The compound features a unique structural configuration that includes a benzodioxin moiety, which contributes to its bioactive properties.
  • Potential Applications: Compounds with similar structures have been explored for their neuroprotective and antidepressant effects, making them candidates for therapeutic research.
  • Research Significance: The presence of the ethanamine segment suggests potential interactions with neurotransmitter systems, which is a critical aspect for developing psychoactive medications.

Research & Implications

The exploration of such compounds is crucial in the quest for new drugs that could revolutionize the treatment of mood disorders. According to scientists, "Understanding the underlying mechanisms of these compounds may lead to innovative therapies." The benzodioxin component is particularly interesting due to its ability to modulate various biological pathways.

Future Directions

Ongoing research aims to elucidate the pharmacological properties and mechanisms of action of 1-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-ethyl-ethanamine. With advancements in synthetic methodologies and biological screening, there is great excitement about the potential to develop new medications from such compounds.

Overall, this compound stands at the crossroads of chemistry and medicine, making it a compelling subject for further study and exploration.

Synonyms
3754-26-5
2-(1-Ethylaminoethyl)-1,4-benzodioxane
BRN 1346438
1,4-BENZODIOXAN, 2-(1-ETHYLAMINOETHYL)-
DTXSID50958623
AKOS014687146
1-(2,3-Dihydro-1,4-benzodioxin-2-yl)-N-ethylethan-1-amine